Skip to main content
Clinical Trials/NCT02955875
NCT02955875CompletedNot Applicable

Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea

Pusan National University0 sites257 target enrollmentStarted: January 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
257
Primary Endpoint
Medications knowledge at 9 months

Study Overview

Brief Summary

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
20 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria
  • Who are diagnosed with type 2 diabetes mellitus for the first time
  • Who need the education for medication or disease
  • Who are with poorly controlled blood glucose
  • Who have poor medication adherence
  • Who have been hospitalized with diabetes complication or poorly controlled blood glucose
  • Whose physician recommend the pharmaceutical care to them

Exclusion Criteria

  • Patients who meet one of the following criteria
  • Who are with gestational diabetes
  • Who are not able to respond to questionnaires
  • Who are with severe condition such as cerebrovascular disease, mental disorder, and acquired immune deficiency syndrome
  • Who are not able to be followed-up during 9 months in Pusan National University Hospital

Arms & Interventions

Pharmaceutical care

Experimental

Participants received systematically organized pharmaceutical care services, which were provided by pharmacists, in addition to the usual care. The usual care includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.

Intervention: Pharmaceutical care (Behavioral)

Usual care

No Intervention

Participants received the usual care, which includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.

Outcomes

Primary Outcomes

Medications knowledge at 9 months

Time Frame: 9 months

Patients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.

Secondary Outcomes

  • EQ Visual Analogue Scale at 9 months(9 months)
  • HbA1c level at 9 months(9 months)
  • Random blood glucose level at 9 months(9 months)
  • Blood pressure at 9 months(9 months)
  • Cholesterol level at 9 months(9 months)
  • Proportion of participants taking statins 9 months(9 months)
  • Proportion of participants managing diabetes complications at 9 months(9 months)
  • Morisky Medication Adherence Scale at 9 months(9 months)
  • 5-level version of the EQ-5D at 9 months(9 months)
  • Problem Areas In Diabetes-Korean questionnaire at 9 months(9 months)
  • Patient Satisfaction Questionnaire-Korean at 9 months(9 months)
  • Cost-effectiveness of pharmaceutical care at 9 months(9 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeong-Hyun Yoon

Associate professor

Pusan National University

Similar Trials

Pharmaceutical Care Service in Diabetes | Clinical Trial